Joint Resolution No. 4 establishes March as Amyloidosis Awareness Month in New Jersey to raise public awareness about amyloidosis, a group of diseases characterized by the accumulation of abnormal proteins called amyloid fibrils in various tissues and organs. The resolution highlights the complexity of diagnosing amyloidosis due to its symptoms often resembling those of more common illnesses, which can lead to many individuals remaining undiagnosed. It emphasizes the importance of early diagnosis and treatment, which can help manage symptoms and prevent further organ damage, as there is currently no cure for the disease.

The resolution calls for the Governor to issue an annual proclamation encouraging public officials and citizens to engage in activities and programs that promote awareness of amyloidosis during March. By designating this month, New Jersey aims to educate the public about the signs and symptoms of the disease, ultimately extending the life expectancy of those who may be suffering from it and improving the quality of life for diagnosed individuals. The resolution takes effect immediately upon approval.